Human perlecan immunopurified from different endothelial cell sources has different adhesive properties for vascular cells

Matrix Biology

Volumn 18, Issue 2, 1999, Pages 163-178

  Whitelock, John M ^a,b   Graham, Lloyd D ^b   Melrose, James ^c   Murdoch, Alan D ^d   Iozzo, Renato V ^d   Anne Underwood, P ^a,b  

^a University of Melbourne   (Australia)

^b CSIRO   (Australia)

^c ROYAL NORTH SHORE HOSPITAL   (Australia)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Adhesion; Endothelial; Human; Perlecan; Smooth muscle

Indexed keywords

HEPARAN SULFATE; PERLECAN; POLYPEPTIDE; PROTEOHEPARAN SULFATE;

ARTERY; ARTICLE; CELL ADHESION; CELL TRANSFORMATION; CELL TYPE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN BINDING; PURIFICATION; VASCULAR SMOOTH MUSCLE; VEIN; WOUND HEALING;

ANIMALS; BINDING SITES; CATTLE; CELL ADHESION; CELL LINE, TRANSFORMED; CELLS, CULTURED; COLLAGEN; ENDOTHELIUM, VASCULAR; FIBROBLAST GROWTH FACTOR 2; FIBRONECTINS; HEPARAN SULFATE PROTEOGLYCANS; HEPARITIN SULFATE; HUMANS; MICE; MUSCLE, SMOOTH, VASCULAR; PROTEOGLYCANS; RATS; SWINE;

EID: 0032893101     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(99)00014-1     Document Type: Article

References (54)

1. Aviezer D., Hecht D., Safran M., Eisinger M., David G., Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell. 79:1994;1005-1013.
2. Battaglia C., Aumailley M., Mann K., Mayer U., Timpl R. Structural basis of beta-1 integrin-mediated cell adhesion to a large heparan sulfate proteoglycan from basement membranes. Eur. J. Cell Biol. 61:1993;92-99.
3. Battaglia C., Mayer U., Aumailley M., Timpl R. Basement-membrane heparan sulfate proteoglycan binds to laminin by its heparan sulfate chains and to nidogen by sites in the protein core. Eur. J. Biochem. 208:1992;359-366.
4. Blum H., Beier H., Gross H.J. Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis. 8:1987;93-99.
5. Brown J.C., Sasaki T., Gohring W., Yamada Y., Timpl R. The C-terminal Domain V of perlecan promotes β1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans. Eur. J. Biochem. 250:1997;39-46.
6. Chakravarti S., Horchar T., Jefferson B., Laurie G.W., Hassell J.R. Recombinant Domain III of perlecan promotes cell attachment through its RGDS sequence. J. Biol. Chem. 270:1995;404-409.
7. Cockerill G.W., Meyer G., Noack L., Vadas M.A., Gamble J.R. Characterization of a spontaneously transformed human endothelial cell line. Lab. Invest. 71:1994;497-509.
8. Costell M., Mann K., Yamada Y., Timpl R. Characterization of recombinant perlecan Domain I and its substitution by glycosaminoglycans and oligosaccharides. Eur. J. Biochem. 243:1997;115-121.
9. Couchman J.R., Kapoor R., Sthanam M., Wu R.R. Perlecan and basement membrane-chondroitin sulfate proteoglycan (Bamacan) are two basement membrane chondroitin dermatan sulfate proteoglycans in the Engelbreth-Holm-Swarm tumor matrix. J. Biol. Chem. 271:1996;9595-9602.
10. David G., Mei Bai X., Van Der Schueren B., Cassiman J.-J., Van Den Berghe H. Developmental changes in heparan sulfate expression: In situ detection with mAbs. J. Cell Biol. 119:1992;961-975.
11. Dolan M., Horchar T., Rigatti B., Hassell J.R. Identification of sites in Domain I of perlecan that regulate heparan sulfate synthesis. J. Biol. Chem. 272:1997;4316-4322.
12. Fazekas de St Groth, S., 1979. The quality of antibodies and cellular receptors. In: Lefkovits, I., Pernis, B. (Eds.), Immunological Methods. Academic Press, pp. 1-42.
13. Gauer S., Schulzelohoff E., Schleicher E., Sterzel R.B. Glomerular basement membrane-derived perlecan inhibits mesangial cell adhesion to fibronectin. Eur. J. Cell Biol. 70:1996;233-242.
14. Gohring W., Sasaki T., Heldin C.-H., Timpl R. Mapping of the binding of platelet-derived growth factor to distinct domains of the basement membrane proteins BM-40 and perlecan and distinction from the BM-40 collagen-binding epitope. Eur. J. Biochem. 255:1988;60-66.
15. Graham, L.D., 1998. Recombinant expression of individual domains from multifunctional proteins. In: Recent Research Developments in Biotechnology and Bioengineering., Research Signpost, Trivandrum, India, pp. 151-165.
16. Groffen A.J.A., Buskens C.A.F., Tryggvason K., Veerkamp J.H., Monnens L.A.H., Vandenheuvel L.P.W.J. Expression and characterization of human perlecan Domains I and II synthesized by baculovirus-infected insect cells. Eur. J. Biochem. 241:1996;827-834.
17. Hagen S.G., Michael A.F., Butkowski R.J. Immunochemical and biochemical evidence for distinct basement membrane heparan sulfate proteoglycans. J. Biol. Chem. 268:1993;7261-7269.
18. Handler M., Yurchenco P.D., Iozzo R.V. Developmental expression of perlecan during murine embryogenesis. Dev. Dynam. 210:1997;130-145.
19. Hassell J.R., Robey P.G., Barrach H.-J., Wilczek J., Rennard S.I., Martin G.R. Isolation of a heparan sulfate-containing proteoglycan from basement membrane. Proc. Natl. Acad. Sci. USA. 77:1980;4494-4498.
20. Hayashi K., Madri J.A., Yurchenco P.D. Endothelial cells interact with the core protein of basement membrane perlecan through β1 and β3 integrins - an adhesion modulated by glycosaminoglycan. J. Cell Biol. 119:1992;945-959.
21. Heremans A., Cassiman J.-J., Van den Berghe H., David G. Heparan sulfate proteoglycan from the extracellular matrix of human lung fibroblasts. J. Biol. Chem. 263:1988;4731-4739.
22. Heremans A., De Cock B., Cassiman J.-J., Van den Berghe H., David G. The core protein of the matrix-associated heparin sulphate proteoglycan binds to fibronectin. J. Biol. Chem. 265:1990;8716-8724.
23. Hiscock D.R.R., Canfield A., Gallagher J.T. Molecular structure of heparan sulfate synthesised by bovine aortic endothelial cells. Biochim. Biophys. Acta. 1244:1995;104-112.
24. Iozzo R.V. Biosynthesis of heparan sulfate proteoglycan by human colon carcinoma cells and its localization at the cell surface. J. Cell. Biol. 99:1984;403-417.
25. Iozzo R.V., Hassell J.R. Identification of the precursor protein for the heparan sulfate proteoglycan of human colon carcinoma cells and its post-translational modifications. Arch. Biochem. Biophys. 269:1989;239-249.
26. Isemura M., Sato N., Yamaguchi Y.et al. Isolation and characterisation of fibronectin-binding proteoglycan carrying both heparan sulfate and dermatan sulfate chains from human placenta. J. Biol. Chem. 262:1987;8926-8933.
27. Kellerman O.K., Ferenci T. Maltose-binding protein from Escherichia coli. Meth. Enzymol. 90:1982;459-463.
28. Klein G., Conzelmann S., Beck S., Timpl R., Muller C.A. Perlecan in human bone marrow: a growth-factor-presenting, but anti-adhesive, extracellular matrix component for hematopoietic cells. Matrix Biol. 14:1995;457-465.
29. Kokenyesi R., Silbert J.E. Formation of heparan sulfate or chondroitin/dermatan sulfate on recombinant Domain I of mouse perlecan expressed in Chinese hamster ovary cells. Biochem. Biophys. Res. Commun. 211:1995;262-267.
30. Kueng W., Silber E., Eppenberger U. Quantification of cells cultured on 96-well plates. Analyt. Biochem. 182:1989;16-19.
31. Lindblom A., Bengtssom-Olivecrona G., Fransson L.A. Domain structure of endothelial heparan sulfate. Biochem. J. 279:1991;821-829.
32. Matthias L.J., Gotis-Graham I., Underwood P.A., McNeil H.P., Hogg P.J. Identification of monoclonal antibodies that recognize different disulfide bonded forms of thrombospondin 1. Biochim. Biophys. Acta. 1296:1996;138-144.
33. McDevitt C.A., Muir H. Gel electrophoresis of proteoglycans and glycosaminoglycans on large pore composite polyacrylamide-agarose gels. Anal. Biochem. 44:1971;612-622.
34. Molist A., Romaris M., Villena J., Bassols A. Enterocytic differentiation correlates with changes in the fine structure and sulfation of perlecan in HT29 human colon carcinoma cells. Biochem. Biophys. Res. Commun. 238:1997;874-879.
35. Morris C.A., Underwood P.A., Bean P.A., Sheehan M., Charlesworth J.A. Relative topography of biologically active domains of human vitronectin. J. Biol. Chem. 269:1994;23845-23852.
36. Murdoch A.D., Dodge G.R., Cohen I., Tuan R.S., Iozzo R.V. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan) - a chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor. J. Biol. Chem. 267:1992;8544-8557.
37. Murdoch A.D., Liu B.A., Schwarting R., Tuan R.S., Iozzo R.V. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against Domain III and by in situ hybridization. J. Histochem. Cytochem. 42:1994;239-249.
38. Noonan D.M., Fulle A., Valente P.et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin-a chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J. Biol. Chem. 266:1991;22939-22947.
39. Paulsson M., Yurchenko P.D., Ruben G.C., Engel J., Timpl R. Structure of low density heparan sulfate proteoglycan isolated from a mouse tumor basement membrane. J. Mol. Biol. 197:1987;297-313.
40. Riggs, P., 1990. Vectors for expression of foreign proteins in Escherichia coli by fusion to maltose-binding protein. In: Ausbel (Ed.), Current Protocols in Molecular Biology, Greene Assoc./Wiley Interscience., New York, pp.
41. Saku T., Furthmayr H. Characterisation of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture. J. Biol. Chem. 264:1989;3514-3523.
42. Schulze B., Sasaki T., Costell M., Mann K., Timpl R. Structural and cell-adhesive properties of three recombinant fragments derived from perlecan Domain III. Matrix Biol. 15:1996;349-357.
43. Sephel G.C., Kennedy R., Kudravi S. Expression of capillary basement membrane components during sequential phases of wound angiogenesis. Matrix Biol. 15:1996;263-279.
44. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gells to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:1979;4350-4354.
45. Turnbull J.E., Fernig D.G., Ke Y., Wilkinson M.C., Gallagher J.T. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J. Biol. Chem. 267:1992;10337-10341.
46. Underwood P.A., Bennett F.A. A comparison of the biological activities of the cell-adhesive proteins vitronectin and fibronectin. J. Cell Sci. 93:1989;641-649.
47. Underwood P.A., Dalton B.A., Steele J.G., Bennett F.A., Strike P. Anti-fibronectin antibodies that modify heparin binding and cell adhesion: evidence for a new cell binding site in the heparin binding region. J. Cell Sci. 102:1992;833-845.
48. Underwood P.A., Kelly J.F., Harman D.F., McMillan H.M. Use of protein a to remove immunoglobulins from serum in hybridoma culture media. J. Immun. Meth. 60:1983;33-45.
49. Underwood P.A., Steele J.G. Practical limitations of estimation of protein adsorption to polymer surfaces. J. Immunol. Meth. 142:1991;83-94.
50. Vigny M., Ollier-Hartmann M.P., Lavigne M., Fayein N., Jeanny J.C., Laurent M., Courtois Dummy Specific binding of basic fibroblast growth factor to basement membrane-like structures and to purified heparan sulfate proteoglycan of the EHS tumor. J. Cell. Physiol. 137:1988;321-328.
51. Vischer P., Feitsma K., Schon P., Volker W. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells Eur. J. Cell Biol. 73:1997;332-343.
52. Weiser M.C.M., Grieshaber N.A., Schwartz P.E., Majack R.A. Perlecan regulates Oct-1 gene expression in vascular smooth muscle cells. Mol. Biol. Cell. 8:1997;999-1011.
53. Whitelock J., Mitchell S., Underwood P.A. The effect of human endothelial cell-derived proteoglycans on human smooth muscle cell growth. Cell Biol. Int. 21:1997;181-189.
54. Whitelock J.M., Murdoch A.D., Iozzo R.V., Underwood P.A. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J. Biol. Chem. 271:1996;10079-10086.